Form 4: ResMed CEO Acquires 12,289 Shares via Performance Vesting

ResMed's CEO, Michael J. Farrell, acquired 12,289 shares of common stock through the vesting of performance-based restricted stock units.

Summary

• Michael J. Farrell, Chief Executive Officer of ResMed Inc. (RMD), acquired 12,289 shares of ResMed Common Stock.
• The acquisition occurred on August 15, 2025, and was a result of performance-based restricted stock units.
• These restricted stock units were originally granted on November 20, 2024.
• The shares were earned because the compensation committee certified that the pre-defined performance metrics were met.
• The stock units are structured to vest 1/3 each year on the anniversary of the grant.
• Following this transaction, Michael J. Farrell directly owns 467,792 shares and indirectly owns 2,090 shares through the Lisette and Michael Farrell Family Trust.

Sentiment

Score: 8

Explanation: The acquisition of shares by the CEO through performance-based vesting indicates successful achievement of company performance metrics, which is a strong positive signal for investors and aligns management's interests with shareholders.

Positives

• CEO Michael J. Farrell acquired 12,289 shares, increasing his direct ownership to 467,792 shares, which enhances alignment with shareholder interests.
• The acquisition resulted from the vesting of performance-based restricted stock units, indicating that the company's compensation committee certified the achievement of specific performance metrics.

Future Outlook

NA

Industry Context

This filing is an insider transaction report, reflecting executive compensation practices common in the medical device and healthcare technology sectors. It does not directly address broader industry trends but indicates internal performance achievements within ResMed.

Related Party Transactions

• Indirect ownership of 2,090 shares through the Lisette and Michael Farrell Family Trust is noted.

Stakeholder Impact

• Shareholders: Increased alignment of CEO's interests with shareholder value due to increased equity ownership.
• Employees: May signal positive company performance and achievement of internal goals.

Next Steps

• Stock units will continue to vest 1/3 each year on the anniversary of the grant.

Key Dates

Recommendation

The acquisition of shares by the CEO stems from the vesting of performance-based restricted stock units, indicating the successful achievement of internal performance metrics. This is a positive sign of management's alignment with shareholder interests and the company's operational success. However, as this is a vesting event rather than an open market purchase, it primarily reinforces a 'hold' position for existing investors, confirming positive internal performance without necessarily signaling a new, immediate catalyst for a 'buy' recommendation.

Keywords

ResMed, RMD, SEC Form 4, Insider Transaction, Stock Acquisition, CEO, Michael J. Farrell, Restricted Stock Units, Performance-Based Compensation, Equity Ownership